Somatic von Hippel-Lindau disease gene mutation in clear-cell renal carcinomas associated with end-stage renal disease/acquired cystic disease of the kidney

scientific article published in December 2002

Somatic von Hippel-Lindau disease gene mutation in clear-cell renal carcinomas associated with end-stage renal disease/acquired cystic disease of the kidney is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/GCC.10123
P8608Fatcat IDrelease_fj6bdnczrza6bkza7sapv6vpby
P698PubMed publication ID12378530

P50authorNoboru NakaigawaQ87997874
P2093author name stringMinoru Yoshida
Isao Ishikawa
Takeshi Kishida
Masahiro Yao
Yoji Nagashima
Kei-ichi Kondo
Masahiko Hosaka
P2860cites workStructure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor functionQ22009393
Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor proteinQ24599442
Identification of the von Hippel-Lindau disease tumor suppressor geneQ29618644
Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCCQ29937783
Renal cell carcinomas in patients on long-term hemodialysisQ33794049
Chasing the cancer demonQ34090719
Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotypeQ35787720
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinomaQ35807817
Acquired cystic kidney disease: occurrence, prevalence, and renal cancersQ38112679
An important von Hippel-Lindau tumor suppressor domain mediates Sp1-binding and self-associationQ40914690
Tumour suppression by the human von Hippel-Lindau gene productQ41320477
Isolation and characterization of 19 dinucleotide repeat polymorphisms on chromosome 3p.Q41790952
Mutations of the VHL tumour suppressor gene in renal carcinomaQ42806703
Novel mutations of the MET proto-oncogene in papillary renal carcinomas.Q42815807
Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomasQ45345804
Three polymorphic dinucleotide repeats near the von Hippel Lindau (VHL) disease gene on human chromosome 3: D3S587; D3S1317; D3S1435.Q53478798
Germ-line mutation analysis in patients with von Hippel-Lindau disease in Japan: an extended study of 77 families.Q55312690
Direct Interaction of the β-Domain of VHL Tumor Suppressor Protein with the Regulatory Domain of Atypical PKC IsotypesQ58323654
High incidence of papillary renal cell tumours in patients on chronic haemodialysisQ70613373
Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC)Q73722184
TNM staging of renal cell carcinoma: Workgroup No. 3. Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC)Q73722193
Chromosomal abnormalities in renal cell neoplasms associated with acquired renal cystic disease. A series studied by comparative genomic hybridization and fluorescence in situ hybridizationQ77976437
P433issue4
P921main subjectvon Hippel-Lindau diseaseQ741315
P304page(s)359-364
P577publication date2002-12-01
P1433published inGenes, Chromosomes and CancerQ5532697
P1476titleSomatic von Hippel-Lindau disease gene mutation in clear-cell renal carcinomas associated with end-stage renal disease/acquired cystic disease of the kidney
P478volume35

Reverse relations

cites work (P2860)
Q83021140Acquired cystic disease-associated renal tumors: an immunohistochemical and fluorescence in situ hybridization study
Q53586772Comparison of prognosis between patients with renal cell carcinoma on hemodialysis and those with renal cell carcinoma in the general population.
Q34092758Genomic profiling of renal cell carcinoma in patients with end-stage renal disease
Q37069569Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors
Q35027407Inhibition of the hypoxia-inducible factor pathway by a G-quadruplex binding small molecule
Q47879190Peroxiredoxins, thioredoxin, and Y-box-binding protein-1 are involved in the pathogenesis and progression of dialysis-associated renal cell carcinoma
Q37778312Perspectives in drug development for metastatic renal cell cancer
Q37507517Uncommon and recently described renal carcinomas

Search more.